section name header

Basics

Alan B. Sanderson, MD


BASICS

DESCRIPTION

EPIDEMIOLOGY

Incidence

No specific data are available.

Prevalence

RISK FACTORS

Genetics

No genetic syndrome is identified.

GENERAL PREVENTION

Smoking cessation, medical management of hypertension, dyslipidemia, and diabetes

PATHOPHYSIOLOGY

ETIOLOGY

COMMONLY ASSOCIATED CONDITIONS

Vascular disease at other sites, including coronary artery disease, carotid stenosis, and peripheral vascular disease.

Diagnosis

DIAGNOSIS

HISTORY

PHYSICAL EXAM

DIAGNOSTIC TESTS AND INTERPRETATION

Lab

Initial Lab Tests

There are no specific laboratory tests.

Follow-Up & Special Considerations

Consider checking serum inflammatory markers in patients suspected of having Takayasu arteritis.

Imaging

Initial Approach

Duplex ultrasound is the initial test of choice because it is noninvasive, relatively inexpensive, has few contraindications, and readily visualizes the direction of flow in vessels (1)[C].

Follow-Up & Special Considerations

CT, MRI, or conventional angiography may also be useful in certain cases, especially if intervention is planned (1)[C].

Pathological Findings

Biopsy is not usually performed. Histology usually shows atherosclerosis. Histology of Takayasu arteritis shows inflammation of the vasa vasorum during the acute phase, and fibrosis with destruction of elastic tissue during the chronic phase (4)[C].

DIFFERENTIAL DIAGNOSIS

Treatment

TREATMENT

MEDICATION

First Line

Second Line

Other antiplatelet agents, such as clopidogrel 75 mg daily.

ADDITIONAL TREATMENT

General Measures

Issues for Referral

Patients should be followed by a vascular surgeon. There are no data to guide the timing or interval of visits (1,2)[C].

SURGERY/OTHER PROCEDURES

Endovascular approaches have been used since the 1990s. A 2009 paper reported 104 consecutive patients treated with either balloon angioplasty alone or angioplasty with stenting, with an overall technical success rate of 96% and sustained 1-year primary patency of 88%. Complication rates are low, and the procedure is less invasive, so many recommend this approach as first-line therapy (2)[B].

IN-PATIENT CONSIDERATIONS

Initial Stabilization

Admission Criteria

There are no specific data to guide management. It is prudent to admit patients who may be candidates for intervention due to severity of symptoms, or who need a number of diagnostic tests to rule out other potential conditions.

IV Fluids

If indicated for hypotension in the setting of active symptoms. There is no preference for one type of IV hydration.

Nursing

Discharge Criteria

There are no specific data to guide management. Clinicians should use their best judgment to discharge patients safely after an appropriately thorough workup, and after watching for and managing any complications of therapy.

Ongoing Care

ONGOING-CARE

FOLLOW-UP RECOMMENDATIONS

PATIENT MONITORING

DIET

PATIENT EDUCATION

PROGNOSIS

The overall prognosis is not known. Whether symptomatic patients improve with medical therapy alone or whether they eventually require procedural intervention is not known.

COMPLICATIONS

Coronary-subclavian steal can occur in patients who have coronary artery bypass surgery using the internal mammary artery.

Additional Reading

SEE-ALSO

Codes

CODES

ICD9

435.2 Subclavian steal syndrome

Clinical Pearls

References

  1. Labropoulos N, Nandivada P, Bekelis K. Prevalence and impact of the subclavian steal syndrome. Ann Surg 2010;252(1):166–170.
  2. Linni K, Ugurluoglu A, Mader N, et al. Endovascular management versus surgery for proximal subclavian artery lesions. Ann Vasc Surg 2008;22(6):769–775. Epub 2008 September 21.
  3. Sixt S, Rastan A, Schwarzwälder U, et al. Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction. Cathet Cardiovasc Interventions 2009;73(3):395–403.
  4. Tsivgoulis G, Heliopoulos I, Vadikolias K, et al. Subclavian steal syndrome secondary to Takayasu arteritis in a young female Caucasian patient. J Neurol Sci 2010;296(1–2):110–111.